During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and aid clinical testing.

A look at the clinical progress of anti-Aβ monoclonal antibodies and how precision delivery is shaping the next generation of ...

Most Alzheimer's disease and nearly half of all dementia was associated with variations in the APOE gene, a study of 470,000 older adults suggested. In all-cause dementia, the two alleles were linked ...

"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...

A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...

Primary care physicians (PCPs) in Ontario frequently used diagnostic tools to assess patients for Alzheimer’s disease and dementia, with usage increasing during follow-up. Antidepressants were ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...